[go: up one dir, main page]

GB202108302D0 - New treatment - Google Patents

New treatment

Info

Publication number
GB202108302D0
GB202108302D0 GBGB2108302.7A GB202108302A GB202108302D0 GB 202108302 D0 GB202108302 D0 GB 202108302D0 GB 202108302 A GB202108302 A GB 202108302A GB 202108302 D0 GB202108302 D0 GB 202108302D0
Authority
GB
United Kingdom
Prior art keywords
new treatment
treatment
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108302.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natco Pharma Ltd
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Priority to GBGB2108302.7A priority Critical patent/GB202108302D0/en
Publication of GB202108302D0 publication Critical patent/GB202108302D0/en
Priority to HUE22732626A priority patent/HUE070017T2/en
Priority to JP2023575997A priority patent/JP7579465B2/en
Priority to MA69391A priority patent/MA69391B1/en
Priority to SI202230087T priority patent/SI4337191T1/en
Priority to CN202280042824.8A priority patent/CN117545476B/en
Priority to MX2023014729A priority patent/MX2023014729A/en
Priority to BR112023025903A priority patent/BR112023025903A2/en
Priority to SM20250035T priority patent/SMT202500035T1/en
Priority to RS20250132A priority patent/RS66487B1/en
Priority to ES22732626T priority patent/ES3007384T3/en
Priority to EP22732626.1A priority patent/EP4337191B1/en
Priority to DK22732626.1T priority patent/DK4337191T3/en
Priority to PCT/GB2022/051450 priority patent/WO2022258977A1/en
Priority to HRP20250177TT priority patent/HRP20250177T1/en
Priority to KR1020247000892A priority patent/KR102713072B1/en
Priority to PL22732626.1T priority patent/PL4337191T3/en
Priority to CA3221808A priority patent/CA3221808A1/en
Priority to FIEP22732626.1T priority patent/FI4337191T3/en
Priority to AU2022291015A priority patent/AU2022291015A1/en
Priority to PT227326261T priority patent/PT4337191T/en
Priority to IL309181A priority patent/IL309181A/en
Priority to LTEPPCT/GB2022/051450T priority patent/LT4337191T/en
Priority to GEAP202416421A priority patent/GEAP202416421A/en
Priority to US18/568,160 priority patent/US20240285642A1/en
Priority to ZA2023/11291A priority patent/ZA202311291B/en
Priority to CL2023003673A priority patent/CL2023003673A1/en
Ceased legal-status Critical Current

Links

GBGB2108302.7A 2021-06-10 2021-06-10 New treatment Ceased GB202108302D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB2108302.7A GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment
US18/568,160 US20240285642A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
DK22732626.1T DK4337191T3 (en) 2021-06-10 2022-06-09 EGFR inhibitor for the treatment of head and neck cancer
HRP20250177TT HRP20250177T1 (en) 2021-06-10 2022-06-09 EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER
MA69391A MA69391B1 (en) 2021-06-10 2022-06-09 EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER
SI202230087T SI4337191T1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
CN202280042824.8A CN117545476B (en) 2021-06-10 2022-06-09 EGFR inhibitors for the treatment of head and neck cancer
MX2023014729A MX2023014729A (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer.
BR112023025903A BR112023025903A2 (en) 2021-06-10 2022-06-09 COMPOUND FOR USE IN THE TREATMENT OF SQUAMOUS CELL CARCINOMA, COMPOUND FOR USE IN THE TREATMENT OF HEAD AND NECK CANCER, METHODS FOR TREATING SQUAMOUS CELL CARCINOMA AND FOR TREATING HEAD AND NECK CANCER AND USES OF A COMPOUND
SM20250035T SMT202500035T1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
RS20250132A RS66487B1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
ES22732626T ES3007384T3 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
EP22732626.1A EP4337191B1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
HUE22732626A HUE070017T2 (en) 2021-06-10 2022-06-09 EGFR inhibitor for the treatment of head and neck cancer
PCT/GB2022/051450 WO2022258977A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
JP2023575997A JP7579465B2 (en) 2021-06-10 2022-06-09 EGFR INHIBITORS FOR THE TREATMENT OF HEAD AND NECK CANCER - Patent application
KR1020247000892A KR102713072B1 (en) 2021-06-10 2022-06-09 EGFR inhibitors for head and neck cancer treatment
PL22732626.1T PL4337191T3 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
CA3221808A CA3221808A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
FIEP22732626.1T FI4337191T3 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
AU2022291015A AU2022291015A1 (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
PT227326261T PT4337191T (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
IL309181A IL309181A (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
LTEPPCT/GB2022/051450T LT4337191T (en) 2021-06-10 2022-06-09 EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER
GEAP202416421A GEAP202416421A (en) 2021-06-10 2022-06-09 Egfr inhibitor for the treatment of head and neck cancer
CL2023003673A CL2023003673A1 (en) 2021-06-10 2023-12-07 EGFR inhibitor for the treatment of head and neck cancer
ZA2023/11291A ZA202311291B (en) 2021-06-10 2023-12-07 Egfr inhibitor for the treatment of head and neck cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108302.7A GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment

Publications (1)

Publication Number Publication Date
GB202108302D0 true GB202108302D0 (en) 2021-07-28

Family

ID=76954593

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108302.7A Ceased GB202108302D0 (en) 2021-06-10 2021-06-10 New treatment

Country Status (1)

Country Link
GB (1) GB202108302D0 (en)

Similar Documents

Publication Publication Date Title
IL312981A (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202116743D0 (en) Treatment
GB202108224D0 (en) Treatment
GB202003722D0 (en) Treatment
GB202006236D0 (en) New treatment
GB202103122D0 (en) Treatment
GB202018400D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202108300D0 (en) New treatment
GB202108302D0 (en) New treatment
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202101897D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101211D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)